HOPKINSON CRAIG C. (EVP R&D, Chief Medical Officer) sold 12.1% of their position (9K shares) of ALKERMES PLC. on the open market
Open‑market sale worth $422.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/1/2026ACC: 0001520262-26-000118
Officer· EVP R&D, Chief Medical Officer
Since Mar 2026
-9K
Net shares
Net seller
$422.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
5K acquired · 14K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+5K
Price / share
$24.59
Trade value
$122.95K
% of position
7.2%
9/1/2026
69.39K→74.39K
Ordinary Shares
Direct
Shares
−9K
Price / share
$46.99
Trade value
$422.87K
% of position
12.1%
9/1/2026
74.39K→65.39K
Total
Net shares
−4K
Net value
-$299.92K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 9/1/2026 | M · Option Exercise | +5K | $24.59 | $122.95K | 7.2% | 69.39K | 74.39K |
| Ordinary Shares Direct | 9/1/2026 | S · Sale | −9K | $46.99 | $422.87K | 12.1% | 74.39K | 65.39K |
| Total | −4K | -$299.92K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Ordinary Shares
5K shares
Shares
−5K
Strike price
24.59
Held after
61.28K
Exercisable
—
9/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Ordinary Shares5K shares | 9/1/2026 | M · Option Exercise | −5K | 24.59 | — | 61.28K |